Last edition
News about "biologics development"
Shilpa Medicare Signs Long-Term Manufacturing and Development Pact with NXI Therapeutics AG
Shilpa Medicare and NXI Therapeutics AG have entered into a long-term agreement to support development and commercial manufacturing of immunomodulatory therapies, expanding Shilpa’s global CDMO footprint in high-growth biologics and specialty therapeutics.
Biologics Development | 14/05/2026 | By News Bureau
Cytiva and Veeda Lifesciences Launch New HCP Services Centre
The collaboration between Cytiva and Veeda Lifesciences brings a dedicated Host Cell Protein (HCP) services centre offering comprehensive HCP coverage, characterization, and quantification assays, enabling global biopharma companies to enhance the safety, efficacy, and quality of their biologics development
Biologics Development | 28/11/2025 | By Dineshwori | 196
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy